Dr. Nooshin Mohd Bazargani, MD, FRCP (Edin)
Consultant Cardiologist
Dubai Hospital
UAE
The Heart Whispers Before It Fails
Recognizing Transthyretin Cardiac Amyloidosis (ATTR-CM)
- 24 June 2026
- 8:00 PM GST
- Virtual Webinar
- CME Accredited
Managed by
Supported by
Event starts in
00
Days
00
Hours
00
Minutes
00
Seconds
24th June 2026 · 08:00 PM GMT +4 (UAE Time)
2
Expert Faculty
4
Live Sessions
90 Min
Live and Interactive
CME
Accredited
Why attend
Listen to the heart. Look deeper.
Transthyretin Cardiac Amyloidosis is underrecognized and often missed until late. This session brings together expert faculty to sharpen early recognition, walk through noninvasive screening and diagnostic tests, and discuss practical management, so the heart is heard before it fails.
Early recognition
Spot the echo and clinical red flags that point to ATTR-CM sooner.
Accurate diagnosis
Noninvasive screening and diagnostic pathways that confirm ATTR-CM.
Better outcomes
Earlier suspicion and timely management improve the patient journey.
Meet the experts
Faculty
Dr. Arif Abdullatif Al-Mulla, MB, BCh, FRCPC, FACC
Advanced Heart Failure and Pulmonary Hypertension Cardiologist
Chief of Cardiology
Dubai Hospital, Dubai Health
UAE
Programme
Agenda
24th June 2026 · 08:00 PM GMT +4 (UAE Time) · Virtual
-
8:00 to 8:05 PM
Opening Remarks
Dr. Nooshin Bazargani
-
8:05 to 8:25 PM
Introduction and Clinical Presentation of ATTR-CM
Dr. Nooshin Bazargani
-
8:25 to 9:15 PM
Noninvasive Screening and Diagnostic Tests of ATTR-CM
Dr. Arif Al Mulla
-
9:15 to 9:30 PM
Q and A
All Faculty
Reserve your place
Registration is quick and free. Secure your seat at this virtual ATTR-CM session and receive joining details by email.
- CME accredited
- Live faculty panel
- No cost to attend
Supported by
Managed by